Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on January 23, 2026

PitPat Launches the 6KM Speed Challenge, Opening a New Chapter in Global Online Cycling Competition
Environmental Mass Spectrometry Market to Reach USD 1.47 Billion by 2031 | MarketsandMarkets™
20 Million Patients Benefit from da Vinci Surgery Globally
Global Polymeric Biomaterials Market to Reach USD 16.93 Billion by 2030 | MarketsandMarkets™
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
Adagene Provides Business Update and 2026 Objectives
Daxor Corporation Announces $9 Million Registered Direct Offering
Aeroflow Health CEO Casey Hite Named to The Healthcare Technology Report’s Top Healthcare Technology CEOs of 2025 List
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
NextCure Provides Business Update 
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions